It's a Wrap: 18 New Pharma-Bio Facilities Complete Construction in 1Q08, an Industrial Info News AlertHighlighted Links

It's a Wrap: 18 New Pharma-Bio Facilities Complete Construction in 1Q08, an Industrial Info News AlertHighlighted Links 

Industrial Info ResourcesSUGAR LAND, TX - Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas) -- The first three months of 2008 saw 18 new pharmaceutical-biotech sites wrap up construction throughout North America. The projects included research and development laboratories and full-scale manufacturing plants. The current capital-spending trends within the industry were definitely reflected within the first-quarter results, with projects sourced out of the medical device sector, the federal government, universities and contract manufacturers. All of the new construction activity was drawn from a recent analysis of new plant development monitored in Industrial Info's Pharmaceutical Tracker.

For details, view the entire article by subscribing to Industrial Info's Premium Industry News at http://www.industrialinfo.com/showNews.jsp?newsitemID=131834, or browse other breaking industrial news stories at www.industrialinfo.com.

Industrial Info Resources (IIR) is a marketing information service specializing in industrial process, energy and financial related markets with products and services ranging from industry news, analytics, forecasting, plant and project databases, as well as multimedia services. For more information send inquiries to [email protected] or visit us at www.industrialinfo.com.

Suggested Articles

More than half of the participants met the primary endpoint, teeing Sanofi up to file for FDA approval of the complement C1s inhibitor.

Cellarity is combining artificial intelligence, a protein discovery platform and what it calls “network biology” in a new drug discovery approach.

Bluebird bio offered the first glimpse of how its CAR-T follow-up is working in multiple myeloma patients who have tried several other treatments.